Anwaar Saeed

University of Pittsburgh

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (11)

Ludimila Cavalcante

Associate Professor, Director, Sarcoma Medical Oncology, Associate Director, Developmental Therapeutics

University of Virginia

UNITED STATES

View details

Emil Lou

University of Minnesota

UNITED STATES

View details

SANJAY GOEL

Rutgers University

UNITED STATES

View details

David J. Pinato

Imperial College London

UNITED KINGDOM

View details

Justin Hwang

Assistant Professor

University of Minnesota

UNITED STATES

View details

Devalingam Mahalingam

Associate Professor of Medicine

Northwestern University Feinberg School of Medicine

UNITED STATES

View details

Ibrahim Halil Sahin

University of Pittsburgh School of Medicine

UNITED STATES

View details

Yu-Chiao Chiu

Assistant Professor

University of Pittsburgh

UNITED STATES

View details

Nicola Personeni

Humanitas University

ITALY

View details

Elizabeth Davis

Vanderbilt University Medical Center

UNITED STATES

View details

Stephen Williamson

Professor Emeritus

UNIVERSITY OF KANSAS SCHOOL OF MEDICINE

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anwaar Saeed

Research Interests

Explore related searches

Contact this professor

Articles (19)

Uncovering PD-L1 among immune cell predictive biomarkers and actionable genetic alterations in anal squamous-cell carcinomas in the era of immunotherapy.

Chemoimmunotherapy in Advanced Biliary Tract Cancers: A Meta-Analysis of Clinical Outcomes

Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: a RAND/UCLA modified Delphi panel study

Emerging targets in gastric and pancreatic cancer: Focus on claudin 18.2

Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort.

Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies

Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric Cancer

Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: a systematic review and meta-analysis

Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results.

Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future

Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era

Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer

Genomic and Transcriptomic Predictors of Response to Immune Checkpoint Inhibitors in Melanoma Patients: A Machine Learning Approach

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study

Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology

Assessing the tumor immune microenvironment in gastric carcinoma: a practical approach

Clinical Evaluation of Ramucirumab for the Treatment of Hepatocellular Carcinoma (HCC): Place in Therapy

Collaborators (11)

Ludimila Cavalcante

Emil Lou

SANJAY GOEL

David J. Pinato

Justin Hwang

Devalingam Mahalingam

Ibrahim Halil Sahin

Yu-Chiao Chiu

Nicola Personeni

Elizabeth Davis

Stephen Williamson

Make your next move.